Electroencephalogram (EEG) in General Anaesthesia - More Than Only a Bispectral Index (BIS)
Recovery From Propofol Anaesthesia Guided by Frontal EEG Wave Analysis Compared to Bispectral Index Monitoring Alone in Laparoscopic Surgery: A Multicentre Double-blind Randomised Controlled Trial
1 other identifier
interventional
232
1 country
4
Brief Summary
Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical parameters to assess the depth of anaesthesia during general anaesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2021
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2019
CompletedFirst Posted
Study publicly available on registry
September 26, 2019
CompletedStudy Start
First participant enrolled
July 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 28, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedApril 18, 2023
April 1, 2023
11 months
September 17, 2019
April 17, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Quality of recovery (QoR): QoR-15 scale
QoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)
24 hours after surgery
Secondary Outcomes (7)
Propofol consumption
during anaesthesia
Quality of recovery (QoR): QoR-15 scale
48 hours after surgery
Time spent in postanaesthesia care unit (PACU)
At arrival to and at discharge from postanaesthesia care unit (an average of 120 minutes)
Time to extubation
At time of skin closure and at time of extubation (an average of 90 minutes)
Risk of awareness
daily from admission up to hospital discharge, an average of approximately 14 days
- +2 more secondary outcomes
Study Arms (2)
Intervention arm
EXPERIMENTALEEG monitoring in addition to standard monitoring (clinical parameters and BIS index)
Control arm
ACTIVE COMPARATORStandard monitoring including clinical parameters and BIS index
Interventions
Standard monitoring including clinical parameters and BIS index
Eligibility Criteria
You may qualify if:
- Adult patients undergoing in-hospital laparoscopic abdominal surgery with general anaesthesia using Propofol based on the Schnider model (target controlled infusion)42, 43
- Minimal duration of surgery of 60 minutes
- Written informed consent
You may not qualify if:
- Same-day surgery
- Language barrier
- Patients under 18 years of age
- Pregnancy (using a beta-human chorionic gonadotropin (HCG) measurement in a blood sample of women in childbearing age)
- Allergy to Propofol
- Administration of hypnotics other than Propofol, such as ketamine or midazolam preoperatively or intraoperatively
- Known brain pathology, such as seizure disorders, dementia, cerebrovascular disease or brain death
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Cantonal Hospital Aarau
Aarau, Switzerland
University Hospital Basel
Basel, Switzerland
Cantonal Hospital Graubünden
Chur, Switzerland
Clinic of Anaesthesiology
Geneva, Switzerland
Related Publications (1)
Gruber BU, Girsberger V, Kusstatscher L, Funk S, Luethy A, Jakus L, Maillard J, Steiner LA, Dell-Kuster S, Burkhart CS. Comparing propofol anaesthesia guided by Bispectral Index monitoring and frontal EEG wave analysis with standard monitoring in laparoscopic surgery: protocol for the 'EEG in General Anaesthesia - More Than Only a Bispectral Index' Trial, a multicentre, double-blind, randomised controlled trial. BMJ Open. 2022 Jun 10;12(6):e059919. doi: 10.1136/bmjopen-2021-059919.
PMID: 35688587DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Salome Dell-Kuster, MD MSc
University Hospital, Basel, Switzerland
- PRINCIPAL INVESTIGATOR
Christoph S Burkhart, MD
Cantonal Hospital Graubünden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2019
First Posted
September 26, 2019
Study Start
July 1, 2021
Primary Completion
May 28, 2022
Study Completion
June 30, 2022
Last Updated
April 18, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will share
Deidentified participant data will be available upon reasonable request from the last authors of this publication (Christoph S. Burkhart, ORCID 0000-0002-9288-117X and Salome Dell-Kuster, ORCID 0000-0001-7219-7138)